IP Library Granted Patent US 10,034,651
Granted Patent B2
US 10,034,651 · App. 14/802,000 · Granted Jul 31, 2018

Brain tissue equivalent material and phantom device comprising the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,034,651
App. No.
14/802,000
Granted
Jul 31, 2018
Kind
B2
Abstract

Compositions, including composition for use in radiographic calibration and quality assurance include glass micro bubbles, epoxy, CaCo 3 , MgO, and Polyethylene. Embodiments of the composition may be used in calibration devices or phantoms. Calibration devices or phantoms constructed of embodiments of the composition may be used in methods of calibrating a radiographic device for imaging of brain tissue.

Claims (65)

1. A composition comprising:

1-4% glass micro bubbles (w/w);

60-80% (w/w) epoxy wherein the epoxy components are present in a 10:4 to 1:1 ratio of resin to polyamine or anhydride;

3-5% CaCO 3 (w/w);

1-3% MgO(w/w);

9-13% Polyethylene (w/w)

3-7% Acrylic Micro Spheres (w/w); and

0-1% Pigment.

2. The composition of claim 1 , for use in radiographic calibration and quality assurance, wherein the concentration of glass micro bubbles is 1.6-3.6% (w/w) and the 60-80% (w/w) epoxy consists of:

50-63% Araldite (w/w); and

18-24% Jeffamine (w/w).

3. The composition of claim 1 , wherein the elemental composition comprises:

Hydrogen at a concentration of 8-9% (w/w);

Carbon at a concentration of 67-68% (w/w);

Nitrogen at a concentration of 1-2% (w/w);

Oxygen at a concentration of 20-21% (w/w);

Chlorine at a concentration of less than 1% (w/w);

Calcium at a concentration of less than 1% (w/w); and

Silicon at a concentration of less than 1% (w/w).

4. The composition of claim 1 , wherein the composition comprises at least one of boron, sodium or a combination thereof.

5. The composition of claim 4 , wherein the boron is at a concentration of less than 1% (w/w) and the sodium is at a concentration of less than 1% (w/w).

6. The composition of claim 1 , wherein the composition consists of:

8.56% Hydrogen;

67.46% Carbon;

1.85% Nitrogen;

20.52% Oxygen;

0.11% Chlorine;

0.75% Calcium;

0.64% Silicon;

0.02% Boron; and

0.1% Sodium.

7. The composition of claim 1 , wherein the composition has a physical density of between 1.045 g/cm 3 and 1.055 g/cm 3 .

8. The composition of claim 1 , wherein the composition is a brain tissue phantom.

9. The composition of claim 1 , wherein the composition mimics radiographic attenuation of brain tissue within ±5 HU for X-ray energies between 40 keV and 140 keV.

10. The composition of claim 9 , wherein the composition mimics radiographic attenuation of brain tissue with ±1 HU for X-ray energies between 40 keV and 140 keV.

11. The composition of claim 1 , wherein the epoxy resin is selected from Araldite, trimethylhexamethylenediamine, Epoxide No. 7, Epikote and combinations thereof and the hardener is selected from Jeffamine, Synolide, aminohexanes, polyoxypropylenetriamines or combinations thereof.

12. A method of calibrating a radiographic device for imaging of brain tissue, the method comprising:

providing a phantom with a brain equivalent material comprising the composition of claim 1 ;

aligning the phantom with the radiographic device;

measuring an attenuation of X-rays by the brain equivalent material; and

calculating a device specific correction factor for the radiographic device from the measured attenuation of the X-rays and a known electron density for the brain equivalent material.

13. The method of claim 12 , further comprising repeating the measurement of the attenuation of the X-rays at a plurality of X-ray energies.

14. The method of claim 12 , wherein the plurality of X-ray energies are between 40 keV and 140 keV.

15. The method of claim 13 , wherein the phantom comprises a plurality of tissue equivalent materials, and further comprising:

measuring an attenuation of the X-rays by each of the plurality of tissue equivalent materials;

plotting the measured attenuations of the X-rays by the tissue equivalent materials and the brain equivalent material against known electron densities for the plurality of tissue equivalent materials and the brain equivalent material; and

wherein the device specific correction factor is calculated from the measured attenuations and the known electron densities.

16. The method of claim 12 , wherein the brain equivalent material is the composition of claim 6 .

17. The method of any one of claims 12 , further comprising applying the device specific correction factor to radiographic images acquired by the radiographic device.

18. A composition comprising:

1-4% glass micro bubbles (w/w);

60-80% (w/w) epoxy wherein the epoxy components are present in a 10:4 to 1:1 ratio of resin to polyamine or anhydride;

3-5% CaCO 3 (w/w);

1-3% MgO(w/w); and

9-13% Polyethylene (w/w)

wherein the composition consists of:

8. 56% Hydrogen;

67. 46% Carbon;

1. 85% Nitrogen;

20. 52% Oxygen;

0.11% Chlorine;

0.75% Calcium;

0.64% Silicon;

0.02% Boron; and

0.1% Sodium.

Assignments (5)
MERGER Recorded Nov 30, 2022
From: GAMMEX, INC.
To: SUN NUCLEAR CORP.
Reel/Frame 061929/0250 →
SECURITY INTEREST Recorded Oct 22, 2021
From: MIRION TECHNOLOGIES (HOLDINGSUB2), LTD.; MIRION TECHNOLOGIES (USHOLDINGS), INC.; MIRION TECHNOLOGIES (US), INC.; MIRION TECHNOLOGIES (CANBERRA), INC.; MIRION TECHNOLOGIES (CONAX NUCLEAR), INC.; SUN NUCLEAR CORP.; GAMMEX, INC.; MIRION TECHNOLOGIES (IST) CORPORATION; BIODEX MEDICAL SYSTEMS, INC.; MIRION TECHNOLOGIES (CAPINTEC), INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 057890/0509 →
RELEASE OF SECURITY INTEREST Recorded Oct 22, 2021
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: MIRION TECHNOLOGIES (RADOS) GMBH; MIRION TECHNOLOGIES (CANBERRA UK) LTD.; MIRION TECHNOLOGIES (CANBERRA) SAS; MIRION TECHNOLOGIES (CANBERRA), INC.; MIRION TECHNOLOGIES (CANBERRA), INC. (F/K/A CANBERRA INDUSTRIES, INC.); MIRION TECHNOLOGIES (CANBERRA) INC. (F/K/A MIRION TECHNOLOGIES (IMAGING), LLC); MIRION TECHNOLOGIES (IST) CORPORATION; MIRION TECHNOLOGIES, INC.; BIODEX MEDICAL SYSTEMS, INC.; GAMMEX, INC.; SUN NUCLEAR CORP.
Reel/Frame 057890/0970 →
SECURITY AGREEMENT Recorded Jan 6, 2021
From: SUN NUCLEAR CORP.; GAMMEX, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 054912/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2015
From: BAIU, CRISTEL
To: GAMMEX, INC.
Reel/Frame 036717/0472 →